Identification of hyperglycemia-associated microbiota alterations in saliva and gingival sulcus

Oral microbes are a contributing factor to hyperglycemia by inducing an increase in insulin resistance resulting in uncontrolled blood glucose levels. However, the relationship between the distribution of oral flora and hyperglycemia is still controversial. Combining the power of MALDI-Biotyper with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of biochemistry and biophysics 2020-03, Vol.682, p.108278-108278, Article 108278
Hauptverfasser: Wei, Yu-Shan, Hsiao, Ya-Chun, Su, Guan-Wei, Chang, Yi-Ru, Lin, Hsiu-Pin, Wang, Yi-Shiuan, Tsai, Yi-Ting, Liao, En-Chi, Chen, Hsin-Yi, Chou, Hsiu-Chuan, Ko, Mei-Lan, Kuo, Wen-Hung, Chang, Shing-Jyh, Cheng, Wen-Chi, Chan, Hong-Lin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Oral microbes are a contributing factor to hyperglycemia by inducing an increase in insulin resistance resulting in uncontrolled blood glucose levels. However, the relationship between the distribution of oral flora and hyperglycemia is still controversial. Combining the power of MALDI-Biotyper with anaerobic bacterial culture, this study explores the correlation between anaerobic bacteria in the oral cavity and blood glucose levels. The results demonstrated that altered blood glucose levels contributed to a varied bacterial distribution in the oral cavity. Specifically, Veillonella spp. and Prevotella spp. were identified in a higher proportion in people with elevated blood glucose levels. Six bacterial species identified in this study (Prevotella melaninogenica, Campylobacter rectus, Streptococcus gordonii, Streptococcus mitis, Streptococcus salivarius, and Veillonella parvula) not only demonstrated a positive association with higher blood glucose levels, but also likely contribute to the development of the condition. The data demonstrated MALDI-TOF MS to be a simpler, faster, and more economical clinical identification tool that provides clarity and depth to the research on blood glucose and oral microbiota.
ISSN:0003-9861
1096-0384
DOI:10.1016/j.abb.2020.108278